Occuity

About Us

Our Mission

Occuity's mission is to provide solutions to some of humanity's greatest health challenges through the development of revolutionary optical technologies to improve the screening & monitoring of chronic health conditions such as diabetes and Alzheimer's Disease.

Founded in 2019, Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored.


Occuity's Intellectual Property includes nine granted international patents with a further five patent applications covering the measurement technique and optical technology that forms the basis of the devices along with additional patents relating to the alignment and measurements within the eye.



Our Products

Optometry & Ophthalmology

We're designing and developing a range of handheld, optical non-contacting devices. Our first device will be the world’s first handheld, non-contacting optical pachymeter – The Occuity PM1 – due to launch in 2022.

The underlying technology in the PM1 will be built upon to look at other measurements within the eye. This is likely to include axial length, pupillometry and keratometry for use in both human and veterinary optometry.

Read More



Disease Screening

Building upon our patented technology, Occuity's disease screening products, will make it easier and cheaper to screen for diseases such as diabetes and Alzheimer's in non-clinical settings such as high street opticians, pharmacies and even domiciliary environments such as care homes.

The technology and devices we are developing will be capable of screening for the AGE's that build up in the eye over time. Coupled with machine learning techniques, the readings from this device will aim to give a diagnosis of whether the subject is non-diabetic, pre-diabetic or diabetic.

Read More



Disease Monitoring

Occuity’s vision is to deliver the world’s first non-invasive, non-contacting glucose monitor.

Instead of relying on finger stick blood tests to provide blood glucose readings, Occuity are in the process of researching & developing a non-contact handheld optical device to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye. There are numerous medical papers that support the direct correlation of changes within the anterior chamber with fluctuations in blood glucose. The glucose monitor under development by Occuity builds on this correlation.

Read More


Join us on our journey. We are crowdfunding on Seedrs.



Useful Information

Occuity successfully raises over £2m to deliver ophthalmic and optical diabetes devices

View document

Find us at an Event

Medica
Dusseldorf, Germany
UK Pavilion
15 Nov - 18 Nov 2021

ADDRESS

The Blade
Abbey Square
Reading
RG1 3BE
United Kingdom

WEBSITE

Visit website

SOCIAL

Let’s connect